Special Issue
Frontiers in oncology: diagnostic approaches and therapeutic strategies
Submission Deadline: 31 December 2009
Articles: 3
Special Issue Editor
Guest Editor
Franco Buonaguro
Member, Experimental Oncology, Via Mariano Semmola n. 1
Expertise: 40 publications, 5 (current) grants, Editor of Frontiers in Bioscience, Infectious Agents and Cancer
Manuscript Submission Information

Manuscripts should be submitted online at https://jour.ipublishment.com/bri by registering and logging into this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All papers will be peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a double-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page.

Please visit the Instructions for Authors page before submitting a manuscript. Submitted papers should be well formatted and written in clear, concise English and should contain all essential data in order to make the presentation clear and the results of the study replicable. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see


Cell Biology, Cancer, Diagnostics, Therapeutics, Molecular Biology
Share This Special Issue
Published Papers (3 papers)
Open Access
Epigenetics and leukemia: unraveling oncogenic processes in the BLV ovine model
Makram Merimi, Yurda Ozkan, Yvette Cleuter, Philip Griebel, Arsene Burny, Philippe Martiat, Anne Van den Broeke
Frontiers in Bioscience-Scholar Volume 1 Issue 1, pp.154-163
Managing Editor: Franco Buonaguro
DOI: 10.2741/S15 Published: 01 June 2009
Open Access
The leukemogenic activity of TaxHTLV-1 during human alphabeta T cell development
Melanie Wencker, Louis Gazzolo, Madeleine Duc Dodon
Frontiers in Bioscience-Scholar Volume 1 Issue 1, pp.194-204
Managing Editor: Franco Buonaguro
DOI: 10.2741/S19 Published: 01 June 2009
Open Access
Gene activation therapy: from the BLV model to HAM/TSP patients
Agnes Lezin, Stephane Olindo, Gildas Belrose, Aissatou Signate, Raymond Cesaire, Didier Smadja, Derek Macallan, Becca Asquith, Charles Bangham, Amel Bouzar, Nicolas Gillet, Julien Defoiche, Arnaud Florins, Olivier Verlaeten, Arsene Burny, Luc Willems
Frontiers in Bioscience-Scholar Volume 1 Issue 1, pp.205-215
Managing Editor: Franco Buonaguro
DOI: 10.2741/S20 Published: 01 June 2009